about
Prostate cancer: 3. Individual risk factorsEvaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancerLinkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators.Krüppel cripples prostate cancer: KLF6 progress and prospectsMultiparametric prostate magnetic resonance imaging in the evaluation of prostate cancerGermline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.Antioncogenes and human cancer.Admixture mapping of prostate cancer in African Americans participating in the North Carolina-Louisiana Prostate Cancer Project (PCaP)Prostate cancer susceptibility loci: finding the genesProstate Cancer Genetics: Variation by Race, Ethnicity, and Geography.Epidemiology of Prostate and Testicular Cancer.Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.Association between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancerScreening for prostate cancer.Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention.Mutation analysis of the MSMB gene in familial prostate cancer.Chromosomal basis of adenocarcinoma of the prostate.Genetics of prostate cancer.The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer.A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity.Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4.Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.Prostate cancer: 2. Natural history.Genetics of prostate cancer: too many loci, too few genesCurrent status of linkage studies in hereditary prostate cancer.Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancerA genomic scan of families with prostate cancer identifies multiple regions of interest.Evidence for a prostate cancer-susceptibility locus on chromosome 20.Linkage analyses at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer.A genome screen of multiplex sibships with prostate cancer.Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer.Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancerBRCA1 and prostate cancer.Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.Prostate cancer in young men: an important clinical entity.Reflections on the cost consequences of the new gene technology for health policy.Evidence for autosomal dominant inheritance of prostate cancer.Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer.
P2860
Q24535097-20A3C898-A69D-416B-BBB1-A2E01717550EQ24536433-904B41A8-9C27-4AD3-8428-4F843A54EFE6Q24538779-B1BFF2C5-164B-4B0F-AAD9-7CA346005D8FQ24684219-85FAC90C-AEC4-46BE-9C4A-0E57BD42FE65Q26776478-9EAF8DFD-148B-47CA-9FA2-C1F9FA35DB74Q27852185-F58C2578-D7A6-4563-A5E9-004FDD622A7FQ28237050-2BDF73AD-293E-4F08-B128-1DDC244C3C33Q28658658-032E1E1B-8216-4575-9F80-5AFE109C8A99Q28752597-19FBAAE1-6A7D-4B84-B1F9-9887E826E319Q30240027-89CAEF0E-EF93-48A6-A902-24113C59A148Q30248216-7B14BBE9-3F0F-492A-B259-20F16AD02340Q30491647-F5FE44D8-5517-4BD1-B890-7493D77BF813Q33597618-565784D1-80F3-4915-B258-B06047B66DF1Q33608384-F630B97F-99A3-4FEA-A4C6-83483C4B5548Q33608788-AD2BCD0C-BFA2-4BEE-AC5C-DAFF2CB5BB15Q33630836-B777B03F-D862-477B-AF7F-9E86D35B983AQ33704075-42EA7F99-204E-4386-B7CA-104DE67F41FAQ33723275-4B848F9F-3806-4A44-ADC2-893B6F1C62D5Q33958709-EC651070-6F4F-431B-A38C-775C518EA5AEQ34020369-B326AB85-BC69-4FF4-9FD4-F800AF4A8B0FQ34020687-F5899AA8-14EB-4F5F-9E08-E8245A69C07FQ34020691-E881D4EB-A827-4B05-B437-D694D2D7BB7AQ34029755-57BD9D62-9F7A-444A-BD0A-763BF5135DAEQ34078064-26414639-2D2D-4FB1-AB97-445F0D49AA73Q34078544-8F757D05-3538-4DF5-8BB5-79F5B7731A90Q34113343-083E95EE-5CB0-4FBD-AD55-24A240DB27B2Q34141779-798A73C4-0470-4093-A8F1-34FFDB431F42Q34141928-589B0A19-064B-4609-B9BA-53A0DCE22670Q34145106-60D8F24C-E7D3-443E-BEB6-AD05BD7792DFQ34145438-F4751F48-A050-4B0C-B575-EB516BE88E20Q34145444-6451BB8F-6849-4E54-BE39-F9903BFC275AQ34147903-4F312231-4B54-4277-B7A4-3E60C99985E3Q34263742-EEAC3F17-9B0B-46CB-BDAB-E5AA62D2148FQ34280860-483CFE39-C3C6-4C83-A264-4D4778BE4984Q34308746-B6A985E8-58C8-4B0D-AA88-93E27522FE9EQ34314644-FF321145-A4A7-4830-9C80-D3331CDA7C7FQ34317706-45D95862-59BF-4A09-8E57-482A5AAA3252Q34385644-9CF00AEC-885A-48B1-8AD2-DE87B59A3780Q34389120-D7931E82-EAA1-4469-A1FE-8075E8A3DED7Q34389363-D698ED08-6345-4D9A-8571-A28EC1DD7EF8
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Mendelian inheritance of familial prostate cancer
@ast
Mendelian inheritance of familial prostate cancer
@en
Mendelian inheritance of familial prostate cancer
@nl
type
label
Mendelian inheritance of familial prostate cancer
@ast
Mendelian inheritance of familial prostate cancer
@en
Mendelian inheritance of familial prostate cancer
@nl
prefLabel
Mendelian inheritance of familial prostate cancer
@ast
Mendelian inheritance of familial prostate cancer
@en
Mendelian inheritance of familial prostate cancer
@nl
P2093
P2860
P3181
P356
P1476
Mendelian inheritance of familial prostate cancer
@en
P2093
B S Carter
G D Steinberg
P2860
P304
P3181
P356
10.1073/PNAS.89.8.3367
P407
P577
1992-04-15T00:00:00Z